Titel

Merkliste
1 Ergebnisse

First-in-child phase I/II study of the dual mTORC1/2 inhibi..:

Morscher, Raphael J ; Brard, Caroline ; Berlanga, Pablo...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2021.08.010. , 2021

Link: https://hal.science/hal-03487880

RT Journal
T1 <Title>First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivaixmarseil:oai:HAL:hal-03487880v1&Exemplar=1&LAN=DE
				
A1 Morscher, Raphael J
A1 Brard, Caroline
A1 Berlanga, Pablo
A1 Marshall, Lynley V
A1 André, Nicolas
A1 Rubino, Jonathan
A1 Aerts, Isabelle
A1 de Carli, Emilie
A1 Corradini, Nadège
A1 Nebchi, Souad
A1 Paoletti, Xavier
A1 Mortimer, Peter G.S
A1 Lacroix, Ludovic
A1 Pierron, Gäelle L
A1 Schleiermacher, Gudrun
A1 Vassal, Gilles
A1 Geoerger, Birgit
PB HAL CCSD; Elsevier
YR 2021
K1 AZD2014
K1 Dual mTOR inhibitor
K1 Molecular enriched phase I/II
K1 Paediatric relapsed refractory cancer
K1 PI3K/AKT/mTOR pathway
K1 Temozolomide
K1 Topotecan
K1 Vistusertib
K1 [SDV.CAN]Life Sciences [q-bio]/Cancer
JF info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2021.08.010
LK http://dx.doi.org/https://hal.science/hal-03487880
DO https://hal.science/hal-03487880
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)